Kidneya Therapeutics

Curated by Signal

Provider of AI-based kidney disease diagnosis platform and drug discovery platform

Overview

Kidneya provides an AI-based kidney disease platform and drug discovery platform. Metabolomics AI-based system for discovering diagnostic tools for CKD/UC (biomarkers/digital biomarkers). The company uses Aristolochic Acid to develop and train AI/ML models which can be used for early diagnosis and prevention of CKD/UC. It also provides a platform for drug discovery.

Key facts

Founded: 2019
Headquarters: Belgrade, Serbia
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Zeopoxa
Various health and fitness related apps
Health TechnologyBelgrade, Serbia
LiveBy
Mobile-based application for monitoring daily habits
Health TechnologySerbia
Divs Technology
Provider of a device to detect diabetes and neurodegenerative disorders
Health TechnologyBelgrade, Serbia

About Kidneya Therapeutics

What does Kidneya Therapeutics do?

Kidneya provides an AI-based kidney disease platform and drug discovery platform.

Where is Kidneya Therapeutics headquartered?

Kidneya Therapeutics is headquartered in Belgrade, Serbia.

When was Kidneya Therapeutics founded?

Kidneya Therapeutics was founded in 2019.

Which sector is Kidneya Therapeutics in?

Kidneya Therapeutics operates in Health Technology.

Who are Kidneya Therapeutics's competitors?

Companies similar to Kidneya Therapeutics include Zeopoxa, LiveBy, and Divs Technology.